Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates
暂无分享,去创建一个
Pablo Villoslada | Nathan Heald | Robert Goertsches | P. Villoslada | S. Hauser | K. Abel | R. Goertsches | C. Genain | Stephen L. Hauser | Kristina Abel | Claude P. Genain | N. Heald
[1] Eric O Long,et al. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. , 1990, Journal of immunology.
[2] N. Letvin,et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. , 1995, The Journal of clinical investigation.
[3] A. Naji,et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide , 2001, Nature Immunology.
[4] L. Hood,et al. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity , 1993, Cell.
[5] Stephen L Hauser,et al. Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen , 1999, Journal of Neuroimmunology.
[6] T. Olsson,et al. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. , 1991, Journal of immunology.
[7] S. Hauser,et al. Late Complications of Immune Deviation Therapy in a Nonhuman Primate , 1996, Science.
[8] S. Hauser,et al. Fine specificities of T cell and B cell responses to myelin/oligodendrocyte glycoprotein in common marmosets , 1998, Journal of Neuroimmunology.
[9] R. Milo,et al. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. , 1993, The Journal of clinical investigation.
[10] C. Brosnan,et al. Mechanisms of Immune Injury in Multiple Sclerosis , 1996, Brain pathology.
[11] S. Hauser,et al. Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis , 2001, European journal of immunology.
[12] K. Nicolay,et al. Myelin/Oligodendrocyte Glycoprotein-Induced Autoimmune Encephalomyelitis in Common Marmosets: The Encephalitogenic T Cell Epitope pMOG24–36 Is Presented by a Monomorphic MHC Class II Molecule1 , 2000, The Journal of Immunology.
[13] A. Cross,et al. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide , 1999, European journal of immunology.
[14] H. Wekerle,et al. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. , 1985, Journal of immunology.
[15] R. Kinkel,et al. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis , 1998, Immunological reviews.
[16] A. Ben-nun,et al. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions , 1997, European journal of immunology.
[17] A. Ben-nun,et al. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse Vβ gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor Vβb and T cell receptor Vβa H‐2b mice , 1996 .
[18] H. Lassmann,et al. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system , 1993, European journal of immunology.
[19] D. Pham‐Dinh,et al. Development of Myelin Oligodendrocyte Glycoprotein Autoreactive Transgenic B Lymphocytes: Receptor Editing In Vivo After Encounter of a Self-Antigen Distinct from Myelin Oligodendrocyte Glycoprotein , 2000, The Journal of Immunology.
[20] B. Devaux,et al. Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide , 1997, Journal of Neuroimmunology.
[21] P. Villoslada,et al. Human Nerve Growth Factor Protects Common Marmosets against Autoimmune Encephalomyelitis by Switching the Balance of T Helper Cell Type 1 and 2 Cytokines within the Central Nervous System , 2000, The Journal of experimental medicine.
[22] R. Hohlfeld,et al. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. , 1997, Brain : a journal of neurology.
[23] I. Cohen,et al. Autoimmunity, microbial immunity and the immunological homunculus. , 1991, Immunology today.
[24] H. Lassmann,et al. Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques. , 1997, The American journal of pathology.
[25] I. Cohen,et al. The cognitive principle challenges clonal selection. , 1992, Immunology today.
[26] D. Bourdette,et al. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis , 1992, Journal of Neuroimmunology.
[27] M. Itoh,et al. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice. , 1999, Cellular immunology.
[28] J. Fjell,et al. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. , 1998, Journal of immunology.
[29] H. Lassmann,et al. Butyrophilin, a Milk Protein, Modulates the Encephalitogenic T Cell Response to Myelin Oligodendrocyte Glycoprotein in Experimental Autoimmune Encephalomyelitis1 , 2000, The Journal of Immunology.
[30] I. Dozmorov,et al. Limiting dilution analysis: from frequencies to cellular interactions. , 2000, Immunology today.
[31] C. Bernard,et al. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. , 1998, Autoimmunity.
[32] J. Strominger,et al. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein , 1995, Cell.
[33] J. Liu,et al. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. , 1996, Journal of immunology.
[34] D. Hafler,et al. Direct Ex Vivo Analysis of Activated, Fas-sensitive Autoreactive T Cells in Human Autoimmune Disease , 1997, The Journal of experimental medicine.
[35] O. Majdic,et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. , 1994, Journal of immunology.
[36] R. Ferrante,et al. In healthy primates, circulating autoreactive T cells mediate autoimmune disease. , 1994, The Journal of clinical investigation.
[37] S. Hauser,et al. Allergic Encephalomyelitis in Common Marmosets: Pathogenesis of a Multiple Sclerosis-like Lesion , 1996, Methods.
[38] S. Hauser,et al. The T‐cell response to myelin basic protein in familial multiple sclerosis: Diversity of fine specificity, restricting elements, and T‐cell receptor usage , 1993, Annals of neurology.
[39] T. Johns,et al. The Structure and Function of Myelin Oligodendrocyte Glycoprotein , 1999, Journal of neurochemistry.
[40] E. Shevach. Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.
[41] H. Lassmann,et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat , 1995, Journal of Neuroimmunology.
[42] R. Voskuhl. Myelin protein expression in lymphoid tissues: implications for peripheral tolerance , 1998, Immunological reviews.
[43] Klaus-Armin Nave,et al. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells , 2000, Nature Medicine.
[44] E. Sercarz,et al. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease , 1993, The Journal of experimental medicine.
[45] S. Hauser,et al. Identification of autoantibodies associated with myelin damage in multiple sclerosis , 1999, Nature Medicine.
[46] R. Hohlfeld,et al. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. , 1999, Brain : a journal of neurology.
[47] H. Wekerle,et al. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic TT cell interactions , 1988, Nature.
[48] Jingwu Z. Zhang,et al. Myelin basic protein–specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity , 1992, Annals of neurology.
[49] B. Engelhardt,et al. Lymphocyte Targeting of the Central Nervous System: A Review of Afferent and Efferent CNS‐Immune Pathways , 1996, Brain pathology.
[50] S. Miller,et al. Evolution of the T‐Cell Repertoire during the Course of Experimental Immune‐Mediated Demyelinating Diseases , 1995, Immunological reviews.
[51] V. Kuchroo,et al. High Frequency of Autoreactive Myelin Proteolipid Protein–Specific T Cells in the Periphery of Naive Mice , 2000, The Journal of experimental medicine.
[52] C. Linington,et al. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily , 1992, Journal of neuroscience research.
[53] A. Ben-nun,et al. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)‐derived peptide: Preliminary analysis of MOG T cell epitopes , 1995, European journal of immunology.
[54] L. Steinman,et al. The T lymphocyte in experimental allergic encephalomyelitis. , 1990, Annual review of immunology.
[55] H. Lassmann,et al. Differential Ultrastructural Localization of Myelin Basic Protein, Myelin/Oligodendroglial Glycoprotein, and 2′,3′‐Cyclic Nucleotide 3′‐Phosphodiesterase in the CNS of Adult Rats , 1989, Journal of neurochemistry.
[56] J. Frank,et al. Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis. , 1999, Journal of immunology.
[57] H. Weiner,et al. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. , 1987, Journal of immunology.
[58] S. Hauser,et al. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen‐specific antibody mediation , 1999, Annals of neurology.
[59] R. Sobel,et al. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice , 1999, Journal of Neuroimmunology.